Nottingham CRO Platelet Services marks fifth anniversary

Nottingham-based contract research organisation (CRO) Platelet Services has recorded a total turnover of over £1.7 million as global demand for the company’s core platelet function testing offering continues to rise.

Platelet Services, which celebrates its fifth anniversary this year, offers a range of standard and customised platelet testing assays to determine the effect of compounds on platelet function. Working with both small drug discovery companies and large pharmaceutical corporations, Platelet Services provides comprehensive expertise and support in drug discovery and development where platelet function testing is required.

Since it was founded in 2018, Platelet Services has experienced year-on-year growth, working with over 50 companies on more than 75 projects (studies). With the view to expand and improve its offering, the company recruited a Chief Scientific Officer in 2021 to guide further growth of the team and optimise processes and deliverables. Since then, the company has welcomed two more members to the team and last year has doubled its lab footprint at BioCity, Nottingham.

Over the last five years, Platelet Services has established and grown an on-site donor panel, ensuring access to high-quality blood samples, as well as investing in two flow cytometers and advanced higher throughput 96-well plate format assays.

Commenting on the milestone, Platelet Services CEO Natalia Dovlatova said: “I am delighted to be celebrating our fifth anniversary and am incredibly proud of the company we have built over the years. Platelet Services is entering a new, exciting development phase, and we plan to continue expanding the team and our lab space, alongside increasing our offering of platelet tests, and potentially working with other cell types in the future. We are looking forward to continuing to solve platelet puzzles and support companies as we aim to make platelet testing more high-throughput and accessible for early-stage drug discovery and development.”

For more information, visit www.plateletservices.com